EPISODE · Apr 24, 2026 · 1 MIN
#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover
Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos'/Resilient's trials. Update to episode #68.
Embed this episode
Ready to play
#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover
0:00
1:48
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Psymposia Podcast?
This episode is 1 minute long.
When was this The Psymposia Podcast episode published?
This episode was published on April 24, 2026.
Can I download this The Psymposia Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!